Sotac Pharmaceuticals Limited (NSE:SOTAC)
India flag India · Delayed Price · Currency is INR
117.00
+5.00 (4.46%)
Apr 17, 2026, 11:54 AM IST

Sotac Pharmaceuticals Company Description

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India.

Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics, IP-lactams and non-IP-lactams, anti-fungal, and cephalosporin products.

The company also offers non-beta lactam general tablets, beta lactam coated tablets, beta lactam uncoated tablets, non-beta lactam general capsules, beta‐lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray and creams.

In addition, it is involved in the research of pharmaceutical molecules used in developing new pharmaceutical formulations; and manufacture of nutraceuticals and food products.

The company also exports its products. Sotac Pharmaceuticals Limited was founded in 2014 and is based in Ahmedabad, India.

Sotac Pharmaceuticals Limited
Country India
Founded 2014
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 127
CEO Sharadkumar Patel

Contact Details

Address:
Plot No. PF-21 & PF-22/A
Ahmedabad, 382110
India
Phone 91 99 1356 2852
Website sotacpharma.com

Stock Details

Ticker Symbol SOTAC
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE0O2D01012
SIC Code 2834

Key Executives

Name Position
Sharadkumar Patel Chief Executive Officer
Brijeshkumar Patel Chief Financial Officer
Pankaj Mahabaleshwarkar Chief Operating Officer